NANOPHASE TECHNOLOGIES CORPORATION 4

4 · NANOPHASE TECHNOLOGIES CORPORATION · Filed Jan 23, 2008

Form 4

Period: 2008-01-22

Director

Transactions

Award
Stock Option (right to buy)
2008-01-22$3.13/sh+15,000$46,950→ 15,000 total
Exercise: $3.13From: 2009-01-22Exp: 2018-01-22→ Common Stock (15,000 underlying)

Holdings

Common Stock
42,144
Stock Option (right to buy)
Exercise: $9.92From: 2002-06-05Exp: 2011-06-05→ Common Stock (2,000 underlying)
2,000
Stock Option (right to buy)
Exercise: $3.50From: 1999-10-29Exp: 2008-10-29→ Common Stock (25,000 underlying)
20,000
Stock Option (right to buy)
Exercise: $5.25From: 1999-06-10Exp: 2008-06-10→ Common Stock (2,000 underlying)
667
Stock Option (right to buy)
Exercise: $5.75From: 1999-02-19Exp: 2008-02-19→ Common Stock (10,000 underlying)
3,334
Stock Option (right to buy)
Exercise: $1.75From: 2000-07-27Exp: 2009-07-27→ Common Stock (10,000 underlying)
6,667
Deferred Common Stock
→ Common Stock (9,290 underlying)
9,290

Footnotes (5)

[F1]Subject to certain restrictions, beginning on this date, options vest in five equal installments.
[F2]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
[F3]Subject to certain restrictions, beginning on this date, options vest in two equal annual installments.
[F4]Each share of deferred common stock represents a right to receive one share of common stock.
[F5]The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.

Documents

1 file